Top 5 Stocks › Ticker track records › LLY

LLY — LLY

Healthcare · AI model ranking history, updated July 13, 2026

12times ranked

+1.5%avg return per entry

6/8exited entries positive

Date	List	Price when added	Return	Status
2026-07-07	Official watchlist	$1,229.29	-3.4%	Tracking
2026-07-07	Daily Top 5	$1,233.18	-3.7%	Tracking
2026-07-07	Daily Top 5	$1,235.56	-3.9%	Tracking
2026-06-26	Official watchlist	$1,168.10	+2.5%	Downside level reached
2026-06-26	Daily Top 5	$1,200.20	-0.3%	Downside level reached
2026-06-24	Official watchlist	$1,127.34	+5.3%	Tracking
2026-06-08	Official watchlist	$1,159.13	+2.5%	Downside level reached
2026-06-08	Daily Top 5	$1,157.03	+2.7%	Downside level reached
2026-06-08	Daily Top 5	$1,149.15	+2.9%	Downside level reached
2026-06-04	Official watchlist	$1,110.99	0.0%	Downside level reached
2026-06-04	Daily Top 5	$1,133.29	0.0%	Downside level reached
2026-05-27	Daily Top 5	$1,083.33	+12.9%	Upside level reached

What the model's reasoning was

2026-07-07: Eli Lilly and Company has rated strong buy by 38 analysts, a standout in the Healthcare sector.
2026-07-07: Eli Lilly and eli Lilly Expands R And D Reach With Abbisko And China Drug Handover, keeping it on the near-term watchlist.
2026-06-26: Eli Lilly and Company stands out after and acquires centessa pharmaceuticals to advance orexin receptor 2 agonists, putting it near the top of today's rankings.

Get tomorrow's Top 5 ranking free, every trading morning

Stock scores, risk ratings and analyst price targets — no charge.

Join free

See the full public performance tracker →

Educational market research only — not financial advice or a recommendation to buy or sell any security. "Return" measures price change from when the AI model added the stock until its upside or downside reference level was reached (an AI model exit recorded), or the latest price while tracking. Past model performance does not guarantee future results. We are not a registered investment advisor.